CODX Historical Balance Sheet
CODX Stock | USD 0.28 0.02 7.69% |
Trend analysis of Co Diagnostics balance sheet accounts such as Other Current Liab of 2.1 M, Total Current Liabilities of 4.2 M or Total Stockholder Equity of 45.7 M provides information on Co Diagnostics' total assets, liabilities, and equity, which is the actual value of Co Diagnostics to its prevalent stockholders. By breaking down trends over time using Co Diagnostics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Co Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Co Diagnostics is a good buy for the upcoming year.
Co Diagnostics Inventory |
|
About CODX Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Co Diagnostics at a specified time, usually calculated after every quarter, six months, or one year. Co Diagnostics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Co Diagnostics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CODX currently owns. An asset can also be divided into two categories, current and non-current.
Co Diagnostics Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Co Diagnostics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Co Diagnostics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Co Diagnostics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Co Diagnostics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most accounts from Co Diagnostics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Co Diagnostics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Co Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.At this time, Co Diagnostics' Property Plant And Equipment Gross is fairly stable compared to the past year. Accumulated Other Comprehensive Income is likely to rise to about 439.4 K in 2025, whereas Total Assets are likely to drop slightly above 52.4 M in 2025.
2022 | 2023 | 2024 | 2025 (projected) | Other Current Liabilities | 1.1M | 2.4M | 2.4M | 2.1M | Total Assets | 123.1M | 95.3M | 64.0M | 52.4M |
Co Diagnostics balance sheet Correlations
Click cells to compare fundamentals
Co Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Co Diagnostics balance sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 71.2M | 160.0M | 123.1M | 95.3M | 64.0M | 52.4M | |
Other Current Liab | 3.4M | 9.6M | 1.1M | 2.4M | 2.4M | 2.1M | |
Total Current Liabilities | 4.5M | 12.6M | 3.9M | 5.7M | 7.3M | 4.2M | |
Total Stockholder Equity | 66.7M | 134.5M | 114.5M | 86.0M | 54.3M | 45.7M | |
Net Tangible Assets | 1.7M | 66.7M | 92.6M | 87.8M | 100.9M | 106.0M | |
Property Plant And Equipment Net | 949.6K | 1.9M | 2.9M | 6.0M | 4.9M | 5.1M | |
Net Debt | (43.0M) | (88.6M) | (22.6M) | (11.9M) | (784.4K) | (823.6K) | |
Retained Earnings | 17.5M | 54.2M | 39.9M | 4.6M | (33.0M) | (31.4M) | |
Accounts Payable | 598.3K | 607.5K | 952.3K | 1.5M | 3.3M | 3.5M | |
Cash | 43.0M | 88.6M | 23.0M | 14.9M | 2.9M | 2.8M | |
Non Current Assets Total | 2.9M | 44.9M | 30.4M | 33.2M | 31.7M | 33.3M | |
Cash And Short Term Investments | 47.3M | 89.9M | 81.3M | 58.5M | 29.7M | 31.3M | |
Common Stock Shares Outstanding | 28.0M | 29.9M | 31.5M | 29.3M | 30.3M | 21.9M | |
Liabilities And Stockholders Equity | 71.2M | 160.0M | 123.1M | 95.3M | 64.0M | 52.4M | |
Capital Surpluse | 26.7M | 49.2M | 80.3M | 88.5M | 101.7M | 106.8M | |
Other Current Assets | 916.3K | 2.3M | 761.2K | 1.6M | 1.3M | 862.3K | |
Other Stockholder Equity | 49.2M | 80.3M | 74.3M | 81.2M | 86.9M | 43.9M | |
Total Liab | 4.5M | 25.6M | 8.6M | 9.3M | 9.7M | 6.7M | |
Total Current Assets | 68.4M | 115.1M | 92.7M | 62.1M | 32.3M | 37.9M | |
Common Stock | 28.6K | 33.8K | 34.8K | 36.1K | 37.9K | 23.5K | |
Property Plant Equipment | 196.8K | 949.6K | 1.9M | 2.5M | 2.9M | 3.1M | |
Non Currrent Assets Other | 1.4M | (484.9K) | 672.7K | (1.0) | 731.1K | 767.6K | |
Net Receivables | 12.1M | 20.9M | 5.4M | 330.9K | 132.6K | 125.9K | |
Common Stock Total Equity | 17.3K | 28.6K | 33.8K | 34.8K | 40.0K | 21.9K | |
Non Current Liabilities Total | 30K | 13.0M | 4.7M | 3.6M | 1.2M | 1.2M | |
Property Plant And Equipment Gross | 949.6K | 2.6M | 4.3M | 8.2M | 8.2M | 8.6M | |
Other Liab | 150K | 30K | 13.0M | 4.6M | 5.3M | 3.3M | |
Retained Earnings Total Equity | (25.0M) | 17.5M | 54.2M | 39.9M | 45.9M | 48.2M | |
Inventory | 8.0M | 2.0M | 5.3M | 1.7M | 1.1M | 1.0M | |
Net Invested Capital | 66.7M | 134.5M | 114.5M | 86.0M | 54.3M | 63.6M | |
Long Term Investments | 1.9M | 75K | 672.7K | 773.4K | 731.1K | 688.0K | |
Net Working Capital | 63.8M | 102.5M | 88.9M | 56.4M | 25.0M | 46.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.